Health & Medicine
Newly Approved Drug for ALS 'Radicava' Costs Over $145,000 a Year
FDA approves new drug for ALS treatment that costs $145,524 annually. More than 20 years after approving the first ever drug for the neurological disorder amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has given its approval to the second drug for ALS treatment.
Latest Research Articles
Parasitic Twin: Indian Baby Born With Another Head on Its Stomach Undergoes Complex Surgery [Warning, Graphic Content]
Sprouting Butterbean Seed Removed Inside Boy's Ear
Walking Could Improve Neural Connectivity, Lowering Risk of Alzheimer's in Older Adults
AIDS Breakthrough: How CRISPR Gene Editing Successfully Eliminated HIV Infection in Animal Models
At 146, World's Oldest Man 'Mbah Ghoto' Dies in Indonesia -- What's His Secret to Long Life?
Report: 1 Out of 4 Americans Drinks Unsafe Water
Scientists Eliminate HIV in Live Animals for the First Time Using CRISPR Gene Editing Technique
WiGait: MIT Designs Wireless Gadget That Predicts Health Issues Based on Walking Speed [Video]
Eating Avocado Linked With Better Nutrient Intake, Diet Quality
Mysterious Illness in Liberia Linked to Funeral of Religious Leader, 12 People Dead
Alcohol Linked to Increased Cases of Breast Cancer in African-American Women
Better Memories Make People Tire of Experiences Quickly, Study Shows
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
-
Northern Lights Could Grace the US Skies Tonight – Here’s Where to Look
